This review aims to address the challenges associated with prescribing SGLT2 inhibitors for diabetes treatment.
Review of existing literature on SGLT2 inhibitors
Assessment of potential side effects
Discussion of management strategies for adverse effects.
SGLT2 inhibitors have expanded in diabetes treatment but present significant side effects.
Management strategies can alleviate issues related to adverse effects.
Review highlights the importance of monitoring and patient education.
Abstract
Use of SGLT2 inhibitors to treat diabetes has expanded greatly over recent years. Here David Morris looks at their possible side effects and how these might be managed